DocuSign’s (DOCU) “Market Outperform” Rating Reiterated at JMP Securities

JMP Securities restated their market outperform rating on shares of DocuSign (NASDAQ:DOCUFree Report) in a report issued on Tuesday,Benzinga reports. They currently have a $124.00 price target on the stock.

DOCU has been the subject of a number of other reports. Citigroup raised their price target on DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Jefferies Financial Group raised their price objective on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company raised their price target on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a report on Friday, December 6th. Finally, Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and an average price target of $92.45.

Get Our Latest Stock Analysis on DOCU

DocuSign Stock Up 1.4 %

Shares of DocuSign stock opened at $89.51 on Tuesday. The firm has a market cap of $18.08 billion, a price-to-earnings ratio of 18.46, a PEG ratio of 8.72 and a beta of 0.88. DocuSign has a twelve month low of $48.70 and a twelve month high of $107.86. The business has a 50-day moving average price of $86.80 and a 200-day moving average price of $68.58.

Insider Buying and Selling

In other news, CFO Blake Jeffrey Grayson sold 9,552 shares of DocuSign stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $68.80, for a total transaction of $657,177.60. Following the transaction, the chief financial officer now owns 78,265 shares in the company, valued at $5,384,632. The trade was a 10.88 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of the company’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the completion of the sale, the director now directly owns 906,430 shares of the company’s stock, valued at $87,959,967.20. This represents a 39.08 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 693,089 shares of company stock worth $66,320,395. Insiders own 1.66% of the company’s stock.

Hedge Funds Weigh In On DocuSign

Several institutional investors and hedge funds have recently bought and sold shares of DOCU. Itau Unibanco Holding S.A. purchased a new stake in DocuSign in the 3rd quarter valued at about $28,000. Brooklyn Investment Group acquired a new position in shares of DocuSign in the 3rd quarter worth approximately $33,000. Modus Advisors LLC purchased a new position in shares of DocuSign during the 4th quarter worth approximately $36,000. Reston Wealth Management LLC acquired a new stake in DocuSign in the 3rd quarter valued at approximately $47,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in DocuSign in the third quarter valued at approximately $51,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Analyst Recommendations for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.